Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Non-Current Assets of $6.8 billion for Q1 2026, up 350.98% year-over-year from $1.5 billion in Q1 2025, and down 10.72% quarter-over-quarter from $7.7 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Non-Current Assets data on file, last reported at $6.8 billion in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $6.8 billion, up 350.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.8 billion (up 1248.01% YoY), and the FY2025 annual result was $7.7 billion, up 21.1% from the prior year.
- Non-Current Assets retreated to $6.8 billion in Q1 2026 per BIO's latest filing, from $7.7 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $11.1 billion in Q1 2022 and troughed at -$3.2 billion in Q4 2022.
- A 5-year average of $4.4 billion and a median of $6.9 billion in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets tumbled 134.92% in 2024, then soared 350.98% in 2026.
- A 5-year view of Non-Current Assets shows it stood at -$3.2 billion in 2022, then grew by 3.46% to -$3.0 billion in 2023, then surged by 307.8% to $6.3 billion in 2024, then advanced by 21.1% to $7.7 billion in 2025, then decreased by 10.72% to $6.8 billion in 2026.
- Business Quant data shows BIO's Non-Current Assets at $6.8 billion in Q1 2026, $7.7 billion in Q4 2025, and $6.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | 6.85 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.67 Bn |
| Sep 30, 2025 | 6.85 Bn |
| Jun 30, 2025 | 7.40 Bn |
| Mar 31, 2025 | -2.73 Bn |
| Dec 31, 2024 | 6.33 Bn |
| Sep 30, 2024 | -3.06 Bn |
| Jun 30, 2024 | -3.06 Bn |
| Mar 31, 2024 | -2.77 Bn |
| Dec 31, 2023 | -3.05 Bn |
| Sep 30, 2023 | 8.75 Bn |
| Jun 30, 2023 | 8.84 Bn |
| Mar 31, 2023 | 10.39 Bn |
| Dec 31, 2022 | -3.16 Bn |
| Sep 30, 2022 | 8.92 Bn |
| Jun 30, 2022 | 9.43 Bn |
| Mar 31, 2022 | 11.07 Bn |
| Dec 31, 2021 | -1.78 Bn |
| Sep 30, 2021 | 17.49 Bn |
| Jun 30, 2021 | 12.83 Bn |